Effect of Linagliptin on Vascular Inflammation in Patients With Type 2 Diabetes Mellitus
Status:
Terminated
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
Examination of the effect of Linagliptin versus placebo for 6 months on vascular inflammation
of the carotic artery and on abdominal adipose tissue inflammation in patients with diabetes
mellitus type 2. The effect will be assessed by FDG-PET scan.
Furthermore the effect of Linagliptin on the vessel wall volume of the carotid artery will be
assessed by MRI scan and biomarkers of vascular inflammation will be analyzed in blood
samples.